I am a Biomedical Engineer by training and I believe that cross-disciplinary research blending Engineering with Molecular and Cell Biology will greatly advance our understanding of rare and complex diseases and how to treat them.
- EC- Re-MEND - Building REsilience against MEntal illness during ENDocrine-sensitive life stages (2023-2027)
- AIRC- Molecular phenotyping of breast cancer at the single-cell level to predict drug therapy for personalised medicine (2023-2024)
- AIRC- Explore therapeutic resistance of triple negative breast cancer with single-cell transcriptomics and lineage tracing (2023-2024)
- iPC – Individualised Pediatric Cure (2019-2023), European Commission H2020. Role: Beneficiary